Neogap Therapeutics move into clinic with personalized cancer immunotherapy

Nanobiotix’s radiotherapy-activated nanoparticle cancer candidate enters Phase 2

Biosimilars in the UK: Insights from Biocon Biologics

Data integration and its role in advancing personalized medicine

Women in Science: ‘Stay curious, be persistent, and embrace the power of mentorship’, says Kerry Love of Sunflower Therapeutics

Women in Science: Laura Crowell on overcoming imposter syndrome

Women in Science: Dr Jennifer Bradford on following your passions – even if your dream job doesn’t exist yet

Hinge Bio raises $30 million to progress B cell lupus therapy

Regenxbio and Nippon Shinyaku collaborate to develop and commercialize gene therapies for Mucopolysaccharidosis I and II

MaaT Pharma’s microbiome therapy scores phase 3 win

Alchemab and Lilly collaborate to discover and develop ALS therapies

BrainChild Bio advances development of CAR T therapy for pediatric brain tumors

Adcentrx launches Phase 1 study for its next-generation ADC targeting advanced solid tumors

Orbis Medicines bags €90 million Series A to develop oral competitors of biologics

Roche and Prothena’s Parkinson’s antibody treatment fails at phase 2

FDA approves first mesenchymal stromal cell therapy

Teva and Sanofi’s IBD drug hits Phase 2 targets

Orexo and Abera collaborate to develop nasal powder vaccines

nChroma Bio formed by merging genetic medicine companies

Eli Lilly invests $3bn in injectable drug manufacturing facility

Relation and GSK join forces to advance fibrotic diseases and osteoarthritis therapies

GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s

Cell and gene therapy access model launches in US

Antag Therapeutics raises $84 million to advance its weight loss drug into the clinic

Spyre Therapeutics launches Phase 1 trials for its extended half-life IBD therapy